8β,9α-Dihydroxylindan-4 (5),7 (11) -dien-8alpha,12-olide
Selected Variant
HY-N10868
Size: 1 Each
8β,9α-Dihydroxylindan-4 (5),7 (11) -dien-8alpha,12-olide (compound 3), a sesquiterpene, has anti-LIMK1 activity. 8β,9α-Dihydroxylindan-4 (5),7 (11) -dien-8alpha,12-olide has inhibitory property on cell motility[1].
Product Specifications
CAS Number
956707-04-3
UNSPSC
12352005
Target
LIM Kinase (LIMK)
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/8β-9α-dihydroxylindan-4-5-7-11-dien-8alpha-12-olide.html
Solubility
10 mM in DMSO
Smiles
CC([C@H]1C[C@H]1[C@]([C@@H]([C@](O2)3O)O)4C)=C4CC3=C(C)C2=O
Molecular Formula
C15H18O4
Molecular Weight
262.30
References & Citations
[1]Jianjiang Fu, et al. In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancer. Phytomedicine. 2018 Oct 1;49:23-31.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
LIMK1
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881146-500 1x 500 µL
CD86 (C86/1146), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680015-100 1x 100 µL
CD56 / NCAM (123C3.D5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471631-100 1x 100 µL
CD9 (TSPAN29) (Motility-Related Protein-1) (CD9/1631), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682305-500 1x 500 µL
FOXA1 / HNF3A (rFOXA1/1515), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401166-500 1x 500 µL
PAX6 (PAX6/1166), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details